logo

CBAM 494/2025 JANSSEN CILAG/10

Contract award notice · Spain · Last reported Oct 2026

Source: TED Europa

Tender
Contract Award Notice

PNAMSP 126/2025 ACUERDO MARCO UNA ÚNICA EMPRESA POR EL QUE SE FIJAN CONDICIONES PARA SUM.TRACTO SUCESIVO Y PRECIO U. DEL MEDICAMENTO EXCLUSIVO CILTACABTAGEN AUTOLEUCEL 3,20MILL CELULAS/INYECTABLE IV 30 ML-Capac:30;Forma farmacéutica INYECTABLE IV(DENOMINACIÓN COMERCIAL CARVYKTI 3,2×10 6-1×108 CELULAS DISPERSION PARA PERFUSION),PARA HOSP.U.VIRG.ROCÍO,REINA SOFÍA Y REGIONAL,CENTROS ADSCRITOS A CPC D

Status
Closed
Sector
Hospital, Commercial
Location
Spain
Updated
3 Nov 2026
Source
TED Europa

ConstructChat

Ask ConstructChat about CBAM 494/2025 JANSSEN CILAG/10

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Tender Information FAQ

Tender Information

4 Q
The tender “CBAM 494/2025 JANSSEN CILAG/10” is a tender record in Taiyo, linked to the Hospital sector. It is issued for works, goods, or services related to Spain.

Participants

Not available for this record.

Status

Original status

contract award notice

Taiyo status

Closed

Taiyo last update

2026-11-03

Contact

Not available for this record.

Description

Description

PNAMSP 126/2025 ACUERDO MARCO UNA ÚNICA EMPRESA POR EL QUE SE FIJAN CONDICIONES PARA SUM.TRACTO SUCESIVO Y PRECIO U. DEL MEDICAMENTO EXCLUSIVO CILTACABTAGEN AUTOLEUCEL 3,20MILL CELULAS/INYECTABLE IV 30 ML-Capac:30;Forma farmacéutica INYECTABLE IV(DENOMINACIÓN COMERCIAL CARVYKTI 3,2×10 6-1×108 CELULAS DISPERSION PARA PERFUSION),PARA HOSP.U.VIRG.ROCÍO,REINA SOFÍA Y REGIONAL,CENTROS ADSCRITOS A CPC DE SEVILLA,CÓRDOBA Y MÁLAGA,MEDIANTE PROC.NEG.SIN PUBLIC.CON EMPRESA JANSSEN-CILAG,SA,TRAMITE URGENTE

Original sector

Medical equipments, pharmaceuticals and personal care products

Budget

Location

Country

Spain

Source

Source

TED Europa

URL

More Details

Record type

Tender

Sector

Hospital, Commercial

Article published date

2026-10-27

More on this tender

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this tender
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this tender